Abstract:The retinoid X receptor (RXR) heterodimerizes with a variety of nuclear receptors. In addition, RXR forms homodimers in the presence of its ligand, 9-cis-retinoic acid. From deletion and point mutation analysis we present evidence that a short region (amino acids 413 to 443) in the carboxy terminus of RXR alpha is critical for both homo- and heterodimeric interactions as well as for diverse functional activities. In addition, we present evidence that homo- and heterodimer functions can be separated. The deletion of 19 amino acids from the C-terminal end of RXR dramatically reduced the transcriptional activation function of RXR. The removal of 10 additional amino acids resulted in a receptor (delta RXR3) that had completely lost its ligand-dependent homodimer function but retained its heterodimer activities. Heterodimer function was abolished by the deletion of an additional 20 amino acids. Single amino acid substitutions in the region generated receptors with altered RXR homodimer DNA binding, while simultaneous mutation of three Leu residues (Leu-418, -419 and -422) completely abolished both RXR homodimer and heterodimer DNA binding activities. Mutation of Leu-430 to Phe (L430-F) resulted in a receptor that bound to DNA strongly as homodimers in a ligand-independent manner, while another single amino acid exchange (L422-Q) led to a mutant that behaved in a manner exactly opposite to that of wild-type RXR in that the homodimerization of the mutant occurred in the absence of ligand and was inhibited by 9-cis-retinoic acid. In transfection assays, both L422-Q and L430-F failed to act as homodimers but retained their heterodimer function. Our studies demonstrate the unique properties of the RXR ligand binding domain and point to specific residues that mediate homo- and heterodimer activities and ligand-induced conformational switches.

Serine 350 of Human Pregnane X Receptor is Crucial for Its Heterodimerization with Retinoid X Receptor Alpha and Transactivation of Target Genes in Vitro and in Vivo.

Simultaneous Substitution of Phenylalanine-305 and Aspartate-318 of Rat Pregnane X Receptor with the Corresponding Human Residues Abolishes the Ability to Transactivate the CYP3A23 Promoter

Threonine-408 Regulates the Stability of Human Pregnane X Receptor through Its Phosphorylation and the CHIP/Chaperone-Autophagy Pathway

Regulation of drug resistance by human pregnane X receptor in breast cancer.

Epigenetic Regulation of Transcriptional Activity of Pregnane X Receptor by Protein Arginine Methyltransferase 1

Phosphorylation-Induced Ubiquitination and Degradation of PXR through CDK2-TRIM21 Axis

A Novel Pregnane X Receptor-Mediated and Sterol Regulatory Element-Binding Protein-Independent Lipogenic Pathway

Pregnane X Receptor As the “sensor and Effector” in Regulating Epigenome

THE PREGNANE X RECEPTOR BINDS TO RESPONSE ELEMENTS IN A GENOMIC CONTEXT-DEPENDENT MANNER, AND PXR ACTIVATOR RIFAMPICIN SELECTIVELY ALTERS THE BINDING AMONG TARGET GENES

Pregnane X receptor as the "sensor and effector" in regulating epigenome.

Human pregnane X receptor-mediated transcriptional regulation of cytochrome P450 3A4 by some phytochemicals]

Human PXR Forms a Tryptophan Zipper-Mediated Homodimer.

Regulation of PXR in drug metabolism: chemical and structural perspectives

Insights into the critical role of the PXR in preventing carcinogenesis and chemotherapeutic drug resistance

Mutations That Alter Ligand-induced Switches and Dimerization Activities in the Retinoid X Receptor

Retinoids activate the RXR/SXR-mediated pathway and induce the endogenous CYP3A4 activity in Huh7 human hepatoma cells.

Function Annotation of Hepatic Retinoid X Receptor Α Based on Genome-Wide DNA Binding and Transcriptome Profiling.

A Double Transgenic Mouse Model Expressing Human Pregnane X Receptor And Cytochrome P450 3a4

Activation of Human Stearoyl-Coenzyme A Desaturase 1 Contributes to the Lipogenic Effect of Pxr in Hepg2 Cells

Dietary phytochemicals as modulators of human pregnane X receptor

Activation of Pregnane X Receptor Disrupts Glucocorticoid and Mineralocorticoid Homeostasis.